<qa>  What is the name of the STUDY that A PHASE I, OPEN-A PHASE I, OPEN-LABEL, 2 PART MULTICENTRE STUDY TO ASSESS THE SAFETY AND EFFICACY OF OLAPARIB IN COMBINATION WITH CARBOPLATIN IN PATIENTS WITH ADVANCED HER-2 NEGATIVE BREAST CANCER: 